Results 51 to 60 of about 1,041,807 (313)

T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators

Journal of Cardiovascular Development and Disease, 2023
Background: Implantable cardioverter–defibrillators (ICDs) need to reliably detect ventricular tachycardia (VT) and ventricular fibrillation (VF) while avoiding T-wave oversensing (TWOS), which is associated with a risk of inappropriate therapies.
Marc Strik, Sylvain Ploux, Romain Eschalier, Pierre Mondoly, Leslie Fontagne, F. Daniel Ramirez, Michel Haïssaguerre, Pierre Bordachar   +7 more
doaj   +1 more source

European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS)

European Journal of Cardio-Thoracic Surgery, 2019
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk.
C. Blomström-Lundqvist, V. Traykov, P. Erba, H. Burri, J. Nielsen, M. Bongiorni, J. Poole, G. Boriani, Roberto Costa, J. Deharo, L. Epstein, L. Sághy, U. Snygg-Martin, C. Starck, C. Tascini, N. Strathmore   +15 more
semanticscholar   +1 more source

Wearable and Implantable Devices for Continuous Monitoring of Muscle Physiological Activity: A Review

Advanced Science, EarlyView.
Recent advances in materials and device engineering enable continuous, real‐time monitoring of muscle activity via wearable and implantable systems. This review critically summarizes emerging technologies for tracking electrophysiological, biomechanical, and oxygenation signals, outlines fundamental principles, and highlights key challenges and ...
Zhengwei Liao, Ata Golparvar, Mohammad Javad Bathaei, Filipe Arroyo Cardoso, Clementine M. Boutry   +4 more
wiley   +1 more source

Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing

Journal of the American College of Cardiology, 2017
Defibrillation testing (DT) does not improve shock efficacy or reduce the risk for arrhythmic death in patients undergoing routine transvenous implantable cardioverter-defibrillator (ICD) placement and is no longer compulsory for left pectoral transvenous ICDs [(1)][1]. The subcutaneous ICD (S-ICD)
Marc A, Miller, Chandrasekar, Palaniswamy, Srinivas R, Dukkipati, Sujata, Balulad, Jeffrey, Smietana, Aaron, Vigdor, Jacob S, Koruth, Subbarao, Choudry, William, Whang, Vivek Y, Reddy   +9 more
openaire   +2 more sources

Implantable cardioverter-defibrillator utilization [PDF]

Europace, 2011
Following the recent publication of our article1 concerning the European paradox with regard to implantable cardioverter defibrillator (ICD) device utilization in Europe (markedly lower device utilization in Europe compared with the USA), which updated several previous reports,2,3 …
John, Camm, Seah, Nisam
openaire   +2 more sources

EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring [PDF]

, 2014
Aim: Remote follow-up (FU) of implantable cardiac defibrillators (ICDs) allows for fewer in-office visits in combination with earlier detection of relevant findings. Its implementation requires investment and reorganization of care. Providers (physicians
Annemans, Lieven, Beeton, Ian, Broadhurst, Paul, Cross, Stephen, Fernandez-Lozano, Ignacio, Garcia, Enrique, Heidbuchel, Hein, Hindricks, Gerd, Koivisto, Ulla-Maija, Löscher, Steffen, Malinowski, Klaus, Marek, Andrea, Peinado, Rafael, Rivero-Ayerza, Maximo, Romero Garrido, Rafael F, Smala, Antje, Van Erven, Lieselot, Vijgen, Johan   +17 more
core   +3 more sources

Ionic–Bionic Interfaces: Advancing Iontronic Strategies for Bioelectronic Sensing and Therapy

Advanced Science, EarlyView.
Ionic–bionic interfaces for bioelectronics leverage ions as multifunctional mediators that combine mechanical compliance, ionic and electronic functionalities, and therapeutic effects. These systems offer real‐time biosignal transduction, effective wound dressing, responsive drug delivery, and seamless interaction between soft tissues and electronic ...
Yun Goo Ro, Yoojin Chang, Jeeyoon Kim, Seungjae Lee, Sangyun Na, Cheolhong Park, Hyunhyub Ko   +6 more
wiley   +1 more source

Single-chamber Versus Dual-chamber Implantable Cardioverter Defibrillators: Do We Need Physiologic Pacing in The Course? [PDF]

, 2006
Background: Many patients with ICD receive different antiarrhythmic drugs (e.g. sotalol, amiodarone, β-blockers) because of ventricular or atrial tachycardias.
Buck, Thomas, Budeus, Marco, Erbel, Raimund, Sack, Stefan, Wieneke, Heinrich   +4 more
core   +2 more sources

Electric‐Fish‐Inspired Thin Hydrogel Electrocytes Achieve High Power Density and Environmental Robustness

Advanced Science, EarlyView.
This study presents thin, environmentally stable hydrogel power sources inspired by electric fish. Made using layer‐by‐layer spin‐coating with glycerol‐enhanced solutions, they offer precise layer control, long‐term hydration, and anti‐freezing stability.
Dor Tillinger, Wonbae Lee, Haley M. Tholen, Derek M. Hall, Joseph S. Najem   +4 more
wiley   +1 more source

Subcutaneous Implantable Cardioverter-Defibrillator [PDF]

Circulation, 2014
For nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead.
Philip M, Chang, Rahul, Doshi, Leslie A, Saxon   +2 more
openaire   +2 more sources